• May Abdel-Wahab, Beatrix Lahoupe, Alfredo Polo, Eduardo Zubizarreta, Raja R Adnan, Peter Johnston, Arsen Juric, Farid El Haffar, Mathias Andre, and Ahmed Meghzifene.
• Division of Human Health, International Atomic Energy Agency, Vienna, Austria. Electronic address: wahabmay@hotmail.com.
• Lancet Oncol. 2017 Oct 1; 18 (10): e587-e594.

AbstractDuring the past six decades, the International Atomic Energy Agency (IAEA) has helped to address the growing cancer burden, by delivering substantial cancer-related assistance to low-income and middle-income member states. IAEA assistance has primarily been facilitated through sustainable radiotherapy and nuclear medicine programmes to establish safe and effective diagnostic imaging, nuclear medicine, and radiotherapy capacity to safely treat patients with cancer. Planning of a National Cancer Control Programme starts with a needs assessment of all aspects of cancer control in the country to ensure evidence-based strategies are adapted to the country's specific needs. The IAEA offers its member states a tool, known as an integrated mission of Programme of Action for Cancer Therapy Review, to assess the status of national capacities for implementation and delivery of cancer control plans and activities and the readiness to develop and implement a long-term radiation medicine infrastructure and plan to improve capacity.Copyright © 2017 Elsevier Ltd. All rights reserved.

23 keywords...

hide…